Estimated Cancer Prevalence by Cancer Site and Gender, New York City, 2019

Source: New York State Cancer Registry

Site of Cancer	Diagnosed in Last 5 Years			Ever Diagnosed
	Males and Females	Males	Females	Males and Females	Males	Females
All Invasive Malignant Tumors	144,900	67,500	77,300	429,100	192,100	237,000
Oral cavity and pharynx	3,300	2,100	1,200	9,300	5,700	3,600
Esophagus	600	400	200	1,300	900	500
Stomach	2,700	1,500	1,200	7,000	3,900	3,200
Colorectal	12,100	6,200	5,900	38,300	18,100	20,200
Liver / intrahepatic bile duct	2,300	1,600	700	4,500	3,100	1,400
Pancreas	1,800	900	1,000	3,200	1,500	1,700
Larynx	900	700	200	3,200	2,400	700
Lung and bronchus	10,000	4,500	5,500	19,200	8,700	10,500
Melanoma of the skin	4,000	2,100	1,800	13,600	6,700	6,900
Female breast			27,700			91,800
Cervix uteri			1,600			9,400
Corpus uterus and NOS			6,600
Ovary			1,900			6,900
Prostate		24,500			81,800
Testis		1,000			5,200
Urinary bladder (incl. in situ)	5,900	4,400	1,500	16,400	11,900	4,500
Kidney and renal pelvis	5,400	3,400	2,000	15,200	9,300	5,900
Brain and other central nervous system	1,400	800	600	5,400	2,800	2,600
Thyroid	8,900	2,100	6,800	28,000	6,000	22,000
Hodgkin lymphoma	1,200	600	600	6,100	3,100	3,000
Non-Hodgkin lymphomas	6,900	3,500	3,300	20,300	10,300	10,000
Myeloma	3,100	1,600	1,500	5,900	2,900	3,000
Leukemias	4,300	2,400	1,900	11,800	6,500	5,400

Notes

• Estimated number of residents alive as of January 1, 2019, diagnosed with cancer within the last 5 years or anytime in the past, respectively.
• Numbers are rounded to the nearest 100.
• Refer to https://www.naaccr.org/wp-content/uploads/2020/01/CINA12-16.v5.sec1_.pdf for a detailed description of prevalence methodology.